Performance of multi-biomarker panels based on urinary N-terminal osteopontin for prediction of diabetic kidney disease in patients with diabetes mellitus

By sjmartinez • September 16, 2023

Sun L, Wu Y, Sinha SK, Nicholas SB, Zou LX. Performance of multi-biomarker panels based on urinary N-terminal osteopontin for prediction of diabetic kidney disease in patients with diabetes mellitus. Eur J Intern Med. 2023 Sep 13:S0953-6205(23)00325-4. doi: 10.1016/j.ejim.2023.09.004. Epub ahead of print. PMID: 37714773.

Tags: Nephrology, Publications

Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy

Rovin BH, Ronco PM, Wetzels JFM, Adler SG, Ayoub I, Zaoui P, Han SH, Dudani JS, Gilbert HN, Patel UD, Manser PT, Jauch-Lembach J, Faulhaber[...]

Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease

Galindo RJ, Soliman D, Cherñavvsky D, Rhee CM. Correction: Diabetes technology in people with diabetes and advanced chronic kidney disease. Diabetologia. 2024 Sep 10. doi:[...]

Effect of Bimagrumab on body composition: a systematic review and meta-analysis

Kanbay M, Siriopol D, Copur S, Hasbal NB, Güldan M, Kalantar-Zadeh K, Garfias-Veitl T, von Haehling S. Effect of Bimagrumab on body composition: a systematic[...]